Article Information
History
- November 17, 2020.
Article Versions
- Version 1 (June 24, 2020 - 07:27).
- Version 2 (June 25, 2020 - 12:00).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Lise M. Helsingen, MD1,*,#,
- Magnus Løberg, PhD1,*,
- Erle Refsum, PhD1,
- Dagrun Kyte Gjøstein, MA1,
- Paulina Wieszczy, PhD1,
- Prof Ørjan Olsvik, MD2,
- Frederik E. Juul, MD1,
- Ishita Barua, MD1,
- Henriette C. Jodal, MD1,
- Magnhild Herfindal, medical student1,
- Yuichi Mori, PhD1,
- Solveig Jore, PhD3,
- Fridtjof Lund-Johansen, PhD4,
- Prof Atle Fretheim, MD3,
- Prof Michael Bretthauer, MD1,*,
- Prof Mette Kalager, MD1,*,
- for the TRAiN study group
- 1Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway
- 2Institute of Medical Biology, Norwegian Arctic University, Tromsø, Norway
- 3Norwegian Institute of Public Health, Oslo, Norway
- 4Department of Immunology, Oslo University Hospital, Oslo, Norway
- ↵#Correspondence to: Dr. Lise M Helsingen, Clinical Effectiveness Research Group, University of Oslo, Postbox 1089 Blindern, 0317 Oslo, Norway, Email: l.m.helsingen{at}medisin.uio.no
↵* these authors contributed equally
Posted November 17, 2020.
